Pakistan Muslim League-Nawaz (PML-N) of ousted prime minister Nawaz Sharif today suffered a blow when one of its leading candidates for the July 25 general elections was sentenced to life imprisonment by an anti-drug court in a six-year-old case.
The Control of Narcotics Substances (CNS) court in Rawalpindi handed life imprisonment to PML-N leader Hanif Abbasi, who was convicted for misusing ephedrine chemical.
Abbasi, considered very close to Sharif, was contesting the elections against Awami Muslim League chief Sheikh Rashid from Rawalpindi.
The PML-N leader will not be able to contest the upcoming general elections following the narcotics court’s decision.
The court, which announced its decision after six years, acquitted seven other accused in the case while giving them the benefit of doubt.
The ephedrine case surfaced in March 2011 when the then federal minister Makhdoom Shahabuddin told the National Assembly that the government would investigate the alleged allocation of 9,000 kg of ephedrine to pharmaceutical companies.
The Anti-Narcotics Force (ANF) registered a case against nine suspects, including Abbasi, in June 2012.
Abbasi was charged of misusing 500 kg of the controlled chemical ephedrine which he obtained for his company, Gray Pharmaceutical, in 2010.
He allegedly sold it to smugglers instead of using it as medicine.
Those absolved of charges included the son of former prime minister Yousuf Raza Gilani, Ali Musa Gilani and former health minister Makhdoom Shahabuddin.
Abbasi was arrested from the court and was expected to be taken to Adiala Jail where his leader Sharif is already jailed.
The conviction might further vitiate the atmosphere of elections which is already highly charged due to imprisonment of Sharif and his daughter in a corruption case.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.